Item 8.01 Other Events

On January 12, 2021, the Company issued a press release announcing positive topline results from its LiFT ("Liver Fat intervention with oral Testosterone") Phase 2 clinical study. The press release is filed as Exhibit 99.1 and is incorporated herein by reference.

Additionally, the Company will be conducting a webcast/ conference call presenting top-line results from the LiFT study. The Company's materials to be used in the presentation are filed hereto as Exhibit 99.2.

Item 9.01 Financial Statements and Exhibits.






(d)    Exhibits

The following exhibits are filed with this report:





Exhibit No.   Description

  99.1          Press Release announcing Positive Topline Phase 2 Results from LPCN
              1144 Ongoing LiFT Study in Biopsy-Confirmed NASH Subjects

  99.2          LiFT Topline Results at Week 12 Presentation

© Edgar Online, source Glimpses